<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR35">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ouedraogo</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age</article-title>
  <source>PLoS ONE</source>
  <year>2013</year>
  <volume>8</volume>
  <fpage>e78679</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0078679</pub-id>
  <?supplied-pmid 24244339?>
  <pub-id pub-id-type="pmid">24244339</pub-id>
 </element-citation>
</ref>
